Normally, miR-187-5p acts as a tumor suppressor by blocking cell cycle progression, and when miR-187-5p is absent due to HBx inhibition, E2F1 expression increases, facilitating the G1 to S phase transition and driving unchecked cell proliferation. This evidence concerns the gene E2F1 and neoplasm.